Latest filing published 25 Apr 2025 for DNA X, Inc., €40k.
Filing timeline
BuySaleInsider track record
Charles Becher: trading record in brief
Charles Becher discloses dealings in DNA X, Inc. to SEC (Form 4). The record holds 3 filings, for trades running from 26 December 2023 to 23 April 2025.
On the market, this insider has only sold: 1 sale, €40k in total. Besides market trades, the filings include 1 share grant and 1 option exercise. So far in 2025, the count stands at no purchases and 1 sale.
The newest entry dates from 25 April 2025: an open-market sale of €40k, in DNA X, Inc. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Charles Becher
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 31,326 shares@ US$1.4545.8% of flowCommon StockSEC:0001641172-25-006115:0
- 70,671 shares0Common StockSEC:0001493152-25-005764:0
- 125,000 shares@ US$0.41954.2% of flowCommon StockSEC:0001493152-23-046419:0
3 of 3 declarations